Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
It’s impossible to run a global clinical trial of an investigational diabetes drug without ancillary materials. And as one leading multi-national pharmaceutical company recently learned, managing ancillaries can be a challenge every bit as complex as the trial itself.
Download this case study to learn how a sound strategy and solid execution plan enabled this company to overcome the challenges they faced to ensure that their patients received the ancillary products they needed.